GoodRx (NASDAQ:GDRX – Get Free Report) had its price target lowered by Barclays from $10.00 to $6.00 in a research note ...

On Monday, Goodrx Holdings Inc (GDRX) stock saw a modest uptick, ending the day at $4.89 which represents no change from the prior close of of $4.89. The stock opened at $4.98 and touched a low of $4.

In a report released today, Jailendra Singh from Truist Financial maintained a Hold rating on GoodRx Holdings (GDRX – Research Report), ...

Barclays lowered the firm’s price target on GoodRx (GDRX) to $6 from $10 and keeps an Overweight rating on the shares post the Q3 report.

“Admitting no wrongdoing” did not absolve BetterHelp of the internet’s wrath, nor did the approximately $10 refund. Fans have ...

Nov. 12, 2024 — Researchers have found that the way DNA is packaged in cells can directly impact how fast DNA itself is copied during cell division. They discovered that DNA packaging sends ...

Raymond James has recently raised Goodrx Holdings Inc (GDRX) stock to Strong Buy rating, as announced on August 9, 2024, according to Finviz. Earlier, on May 23, 2024, RBC Capital Mkts had raised the ...

Experts share their easy tips for saving on prescriptions. One of the easiest ways to save money on meds is to ask your ...

GoodRx has been hit with a series of antitrust class actions in California and Rhode Island federal courts challenging the ...

Over the past few days, the news from GoodRx Holdings (NASDAQ: GDRX) hasn't been all that good. On Thursday the online ...

Welcome to the GoodRx third-quarter 2024 earnings call. As a reminder, today's conference call is being recorded. I would now ...